“Cysteamine: Clinical Efficacy, Safety and Tolerability Versus Best-in-Class Treatments for Melasma ”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s88, https://doi.org/10.25251/skin.5.supp.88.